The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
1,000 jobs Number of planned job losses
Announcement Date
19 August 2015
Employment effect (start)
19 August 2015
Foreseen end date
Description
Danish pharmaceutical producer Lundbeck is to cut around 1000 jobs or around 17% of the company’s workforce. The job cuts will take place at the company's Copenhagen headquarters and in other company units around the world. The announcement comes despite a better forecast for the company financially, and an increased focus on research and development for new drugs within the company. Competition from generic drugs producers and the lapse of patents on some of the company's main pharmaceutical lines are cited as reasons for the restructuring.
Sources
19 August 2015: Bloomberg Business
19 August 2015: Reuters
19 August 2015: Pharmaforum
Citation
Eurofound (2015), Lundbeck, Internal restructuring in World, factsheet number 84722, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/84722.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
